References
- Bateman ED, Boushey HA, Bousquet J, Busse WW, Clark TJ, Pauwels RA, et al. Can guideline-defined asthma control be achieved? The gaining optimal asthma control study. Am J Respir Crit Care Med 2004;170:836–44.
- Agarwal R, Khan A, Aggarwal AN, Saikia B, Gupta D, Chakrabarti AA. Role of inhaled corticosteroids in the management of serological allergic bronchopulmonary aspergillosis (ABPA). Intern Med 2011;50:855–60.
- Crompton GK, Sanderson R, Dewar MH, Matusiewicz SP, Ning AC, Jamieson AH, et al. Comparison of pulmicort pMDI plus nebuhaler and pulmicort turbuhaler in asthmatic patients with dysphonia. Respir Med 2000;94:448–53.
- Lavy JA, Wood G, Rubin JS, Harries M. Dysphonia associated with inhaled steroids. J Voice 2000;14:581–8.
- Holbrook WP. Bacterial infections of oral soft tissues. Curr Opin Dent 1991;1:404–10.
- Kirkpatrick MB, Bass JB Jr. Quantitative bacterial cultures of bronchoalveoler lavage fluids and protected brush catheter specimens from normal subjects. Am Rev Respir Dis 1989;139:546–8.
- Rachelefsky GS, Liao Y, Faruqi R. Impact of inhaled corticosteroid-induced oropharyngeal adverse events: results from a meta-analysis. Ann Allergy Asthma Immunol 2007;98:225–38.
- Van Boven JF, de Jong-van den Berg LT, Vegter S. Inhaled corticosteroids and the occurrence of oral candidiasis: a prescription sequence symmetry analysis. Drug Saf 2013;36:231–6.
- Karaman E, Enver O, Alimoglu Y, Gonullu N, Bahar T, Torun MM, et al. Oropharyngeal flora changes after tonsillectomy. Otolaryngol Head Neck Surg 2009;141:609–13.
- Zhang L, Prietsch SO, Mendes AP, Von Groll A, Rocha GP, Carrion L, et al. Inhaled corticosteroids increase the risk of oropharyngeal colonization by Streptococcus pneumoniae in children with asthma. Respirology 2013;18:272–7.
- Enrique A, Ferrer A, Lorente J, Quesada JL, Gasser I. Tracheal infection following oncological surgery in larynx and pharynx. Acta Otorrinolaringol Esp 2006;57:183–5.
- Ozuguz P, Callioglu EE, Tulaci KG, Kacar SD, Balta I, Asik G, et al. Evaluation of nasal and oropharyngeal flora in patients with acne vulgaris according to treatment options. Int J Dermatol 2014;53:1404–8.
- Doern CD, Burnham CA. It's not easy being green: the viridans group streptococci, with a focus on pediatric clinical manifestations. J Clin Microbiol 2010;48:3829–35.
- Chmielewska M, Akst LM. Dysphonia associated with the use of inhaled corticosteroids. Curr Opin Otolaryngol Head Neck Surg 2015;23:255–9.
- Horita N, To M, Araki K, Haruki K, To Y. Risk factors of local oropharyngeal and laryngeal adverse effects from use of single inhaled corticosteroids and long-acting beta-agonists. Allergol Int 2012;61:583–8.
- Wong KK, Pace-Asciak P, Wu B, Morrison MD. Laryngeal candidiasis in the outpatient setting. J Otolaryngol Head Neck Surg 2009;38:624–7.
- Ohlin A, Björkman L, Serenius F, Schollin J, Kallen K. Sepsis as a risk factor for neonatal morbidity in extremely preterm infants. Acta Paediatr 2015;104:1070–6.
- Balletto E, Mikulska M. Bacterial infections in hematopoietic stem cell transplant recipients. Mediterr J Hematol Infect Dis 2015;7:e2015045.
- Xu H, Sobue T, Thompson A, Xie Z, Poon K, Ricker A, et al. Streptococcal co-infection augments Candida pathogenicity by amplifying the mucosal inflammatory response. Cell Microbiol 2014;16:214–31.
- Krouse J. The unified airway-conceptual framework. Otolaryngol Clin 2008;41:257–66.